Purapharm Corp Ltd
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Oncozac, Haveron, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services, and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong. Show More...
-
Website https://www.purapharm.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 0.50 HKD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share HKD 70.4 0.14 0.14 0.010 0.08 -0.82 -0.82 Dividends HKD 0.08 0.02 Payout Ratio % * 38.3 14.1 Shares Mil 207.0 237.0 253.0 272.0 276.0 276.0 Book Value Per Share * HKD 0.54 1.87 2.08 2.15 1.85 0.92 Free Cash Flow Per Share * HKD -0.41 -0.68 -0.13 0.12 Return on Assets % 8.2 5.09 4.13 0.18 1.58 -17.79 -17.79 Financial Leverage (Average) 3.1 1.48 1.89 2.36 2.37 3.38 3.38 Return on Equity % 25.4 9.4 6.96 0.38 3.74 -49.17 -49.17 Return on Invested Capital % 13.99 7.69 6.0 1.67 3.41 -20.36 -20.36 Interest Coverage 4.24 4.92 5.14 1.61 2.21 -6.95 -6.95 Current Ratio 1.08 2.4 1.64 1.01 1.22 0.94 0.94 Quick Ratio 0.57 1.74 1.09 0.48 0.66 0.47 0.47 Debt/Equity 0.1 0.29 0.51 0.51